Regulatory Science Symposium: Patient-Centered Drug Development and Real World Evidence/Data Session 6: Case Study: From Discovery to Practice and Survivorship (2019)

Data Management & Informatics
Regulatory & Quality Sciences
Regulatory Science Symposium: Patient-Centered Drug Development and Real World Evidence/Data Session 6: Case Study: From Discovery to Practice and Survivorship (2019)
Jerry S. H. Lee, PhD

Chief Science and Innovation Officer, Lawrence J. Ellison Institute; Associate Professor of Clinical Medicine and Chemical Engineering at Keck School of Medicine and Viterbi School of Engineering

Topics

  1. My perspective
  2. Tumor, Cancer and Metastasis – Length and Time Scale Matter
  3. Phases of Translational Science
  4. Clinical Pharmacology & Therapeutics
  5. APOLLO Network
  6. Precision Health and Precision Oncology
  7. What is Water?
  8. First Pass at Cancer Genome Reveals Complex Landscape
  9. Rapid Acceleration from Stimulus Funding (2009-2011)
  10. Getting “Water” Just Right
  11. The Cancer Genome Atlas
  12. NCI-MATCH Central Screening Summary
  13.  Central Dogma of Biology
  14. Re-writing Central Dogma (2016)
  15. Don’t forget Imaging!
  16. Without a National Learning Healthcare System for Cancer
  17. Cancer Moonshot Data & Technology Team
  18. MCC: Military Clinical Trials Network
  19. APOLLO: Applied Proteogenomics Organizational Learning and Outcomes Network
  20. Patient Trajectory Comprised of all Relevant Cancer Case and Cofactor Trajectories
  21. APOLLO-5 Dashboard Pilot
  22. Big Data Scientist Training Enhancement Program (BD-STEP)

Acknowledgement

Accompanying text created by Khyati Ashtekar | Graduate Student, Regulatory Science, USC School of Pharmacy | ashtekar@usc.edu

Video Series

Regulatory Science Symposium: Patient-Centered Drug Development and Real World Evidence/Data Session 6: Case Study: From Discovery to Practice and Survivorship (2019) View Video Series
View More Courses >

NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.

This program is open to all eligible individuals. SC CTSI operates all of its programs and activities consistent with the University’s Notice of Non-Discrimination. Eligibility is not determined based on race, sex, ethnicity, sexual orientation, or any other prohibited factor.